|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Provision for credit losses | |||||
| Stock-based compensation expense | |||||
| Amortization of intangible assets | |||||
| Tax Credit, Investment, Amortization Cash Flow | |||||
| Origination of mortgage loans held for sale | |||||
| Proceeds from sale of mortgage loans held for sale | |||||
| Total Deferred tax expense (benefit) | |||||
| Bank owned life insurance income | |||||
| Valuation adjustment on interest rate swaps | |||||
| Gain on sale of mortgage loans held for sale, net | |||||
| Loss on sale of investment securities, net | |||||
| Gain on sale of premises and equipment | |||||
| Gain on sale of branch | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Loan originations and purchases, net of payments | |||||
| Maturities and repayments of investment securities available for sale | |||||
| Maturities and repayments of investment securities held to maturity | |||||
| Purchase of investment securities available for sale | |||||
| Purchase of investment securities held to maturity | |||||
| Proceeds from sales of investment securities available for sale | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sales of other loans | |||||
| Proceeds from redemption of Federal Home Loan Bank stock | |||||
| Purchases of Federal Home Loan Bank stock | |||||
| Proceeds from sales of premises and equipment | |||||
| Purchases of bank owned life insurance | |||||
| Proceeds from bank owned life insurance death benefit | |||||
| Cash received from return of NMTC equity method investment | |||||
| Payments for (Proceeds from) Life Insurance Policies | |||||
| Capital contributions to tax credit partnerships | |||||
| Net cash paid related to branch divestiture | |||||
| Net cash provided (used) by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase (decrease) in deposits | |||||
| Proceeds from borrowings | |||||
| Repayment of borrowings | |||||
| Common stock cash dividends paid | |||||
| Net decrease in securities sold under agreement to repurchase | |||||
| Repurchase of common stock | |||||
| Net cash (used) provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
| Supplemental non-cash disclosures of cash flow information: | |||||
| Transfer of investment securities available for sale to held to maturity | |||||
| Investment in LIHTC partnerships and related funding commitment | |||||
| Loans received from return of NMTC equity method investment | |||||
| ROU assets obtained in exchange for new operating lease liabilities | |||||
| Transfers of premises and equipment classified as held for sale to prepaid expenses and other assets from premises and equipment, net | |||||
| Transfer of Bank Owned Life Insurance To Prepaid Expenses And Other Assets Due to Surrender | |||||
| Transfer of bank owned life insurance to prepaid expenses and other assets due to death benefit accrued, but not received | |||||
| Transfer of deposits to deposits held for sale | |||||
Loading...
